- Home
- SRDX
SRDX
Surmodics Inc.
as 03-31-2025 3:43pm EST
| Founded: | 1979 | Country: | United States |
| Employees: | N/A | City: | EDEN PRAIRIE |
| Market Cap: | N/A | IPO Year: | 1998 |
| Target Price: | $43.00 | AVG Volume (30 days): | 169.0K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.17 - $42.44 | Next Earning Date: | 04-30-2025 |
| Revenue: | $125,448,000 | Revenue Growth: | -9.23% |
| Revenue Growth (this year): | 6.47% | Revenue Growth (next year): | 4.99% |
Latest Surmodics Inc. News
SRDX Breaking Stock News: Dive into SRDX Ticker-Specific Updates for Smart Investing
Zacks
14 days ago
Here's Why You Should Retain Surmodics Stock in Your Portfolio Now
Medical Device Network
21 days ago
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics
Zacks
24 days ago
SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge
MedTech Dive
25 days ago
FTC challenges $627M private equity takeover of Surmodics
MT Newswires
25 days ago
Surmodics Vows to Oppose FTC Decision to Block GTCR Deal
Business Wire
25 days ago
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR
Reuters
25 days ago
US FTC sues to block private equity purchase of medical company
Zacks
2 months ago
SurModics (SRDX) Loses -13.87% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Compare SRDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRDX Surmodics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.